MYC and neoplasm: The correlation suggests that circadian physiology might be compromised in tumours with amplified MYC. Strategies targeting the interaction of MYC with MIZ1 could help to recover circadian control over cellular physiology in malignant cells and potentially inhibit uncontrolled growth without major effects on differentiated post-mitotic cells with low MYC expression.